» We opened an office in the UAE in the middle of July 2021 . Demographic wise , the population in the UAE are blessed with a younger population . As our solution is looking to support dementia diagnosis and older populations that the AI platform has been trained on is not the primary driver as to why people are looking at our solutions . The demographics in this region are more interested in the wellbeing part of what our technology offers . The uptake has been amazing . We have been in discussions with the Ministry of Health , the Dubai Health authority and big chain hospitals like Mediclinic . All of these players have a very strong interest in adopting the technology in various scopes of its service , being the clinical application or the lifestyle wellness development app .

» Our solution is fully commercialised , is CE marked and an FDA class-II medical device . It has been adopted by the NHS for remote monitoring and detection of cognitive impairments and we are now in the process of widening our presence globally . We have always been active in continuing to validate the technology consistent research and collaboration with bodies like the NHS and Alzheimer ' s Society in the UK .

“ Our solution is perfect and it has been adopted by the NHS for remote monitoring and development of cognitive impairments ”